Graves Adrienne L
Harrow Health, Inc. · Director
Graves Adrienne L is listed in public filings as director. This Graves Adrienne L insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Harrow Health, Inc. (HROW), Opus Genetics, Inc. (IRD), and Ocular Therapeutix, Inc. (OCUL). Investors use Graves Adrienne L's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $31k1k shares | BuyMay 18, 2026 | $31.1K1k shares | $31.07 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --127.5k shares | Grant / ExerciseApr 20, 2026 | Disclosure amount unavailable24.4k shares | -- | -- | |
| $205k103.1k shares | Grant / ExerciseJan 1, 2026 | $47.0K23.6k shares | $1.99 | -- | |
| --7.3k shares | Grant / ExerciseJun 20, 2025 | Disclosure amount unavailable7.3k shares | -- | -- | |
| $388k44k shares | Grant / ExerciseJun 11, 2025 | $388.1K44k shares | $8.82 | -- | |
| --50k shares | Grant / ExerciseJun 11, 2025 | Disclosure amount unavailable14k shares | -- | -- | |
| --79.5k shares | Grant / ExerciseApr 30, 2025 | Disclosure amount unavailable79.5k shares | -- | -- | |
| $76k79.6k shares | Grant / ExerciseApr 30, 2025 | $75.6K79.6k shares | $0.95 | -- | |
| $230k172.9k shares | Grant / ExerciseOct 22, 2024 | $229.9K172.9k shares | $1.33 | -- | |
| $285k36k shares | Grant / ExerciseJul 24, 2024 | $284.8K36k shares | $7.91 | -- | |
| --36k shares | Grant / ExerciseJul 24, 2024 | Disclosure amount unavailable12k shares | -- | -- | |
| --8.3k shares | Grant / ExerciseJun 14, 2024 | Disclosure amount unavailable8.3k shares | -- | -- |